Home/Filings/4/0000950170-25-013647
4//SEC Filing

SIMARD JOHN 4

Accession 0000950170-25-013647

CIK 0001626878other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:53 PM ET

Size

5.4 KB

Accession

0000950170-25-013647

Insider Transaction Report

Form 4
Period: 2025-01-31
SIMARD JOHN
DirectorChief Executive Officer10% Owner
Transactions
  • Other

    Convertible Loan Agreement

    2025-01-31$10000000.00/sh2,470,355$24,703,550,000,000870,381 total
    Exercise: $4.05From: 2024-01-03Exp: 2029-01-03Common Shares or Preferred Shares (2,470,335 underlying)
Footnotes (1)
  • [F1]On January 31, 2025, the Convertible Loan Agreement (the "Loan") dated as of January 3, 2024 between XBiotech Inc. and John Simard, the Company's Founder, President, Chief Executive Officer, and Chairman, was terminated upon full repayment of the Loan by the Company. As a result, all conversion rights to XBiotech stock associated with the Loan were extinguished.

Documents

1 file

Issuer

XBiotech Inc.

CIK 0001626878

Entity typeother

Related Parties

1
  • filerCIK 0001639078

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:53 PM ET
Size
5.4 KB